Clover Corporation Limited's (ASX:CLV) P/E Is On The Mark




  • In Business
  • 2020-09-18 23:12:31Z
  • By Simply Wall St.
Clover Corporation Limited\
Clover Corporation Limited\'s (ASX:CLV) P/E Is On The Mark  

Clover Corporation Limited's (ASX:CLV) price-to-earnings (or "P/E") ratio of 36.3x might make it look like a strong sell right now compared to the market in Australia, where around half of the companies have P/E ratios below 19x and even P/E's below 11x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.

Recent times have been pleasing for Clover as its earnings have risen in spite of the market's earnings going into reverse. The P/E is probably high because investors think the company will continue to navigate the broader market headwinds better than most. If not, then existing shareholders might be a little nervous about the viability of the share price.

Check out our latest analysis for Clover

Keen to find out how analysts think Clover's future stacks up against the industry? In that case, our free report is a great place to start.

What Are Growth Metrics Telling Us About The High P/E?

In order to justify its P/E ratio, Clover would need to produce outstanding growth well in excess of the market.

If we review the last year of earnings growth, the company posted a terrific increase of 15%. Pleasingly, EPS has also lifted 181% in aggregate from three years ago, thanks to the last 12 months of growth. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

Looking ahead now, EPS is anticipated to climb by 35% during the coming year according to the twin analysts following the company. With the market only predicted to deliver 21%, the company is positioned for a stronger earnings result.

In light of this, it's understandable that Clover's P/E sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

The Key Takeaway

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

As we suspected, our examination of Clover's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.

A lot of potential risks can sit within a company's balance sheet. Take a look at our free balance sheet analysis for Clover with six simple checks on some of these key factors.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a P/E below 20x.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

COMMENTS

More Related News

Announcing: BioTelemetry (NASDAQ:BEAT) Stock Increased An Energizing 201% In The Last Five Years
Announcing: BioTelemetry (NASDAQ:BEAT) Stock Increased An Energizing 201% In The Last Five Years

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Is It Too Late To Consider Buying Barrett Business Services, Inc. (NASDAQ:BBSI)?
Is It Too Late To Consider Buying Barrett Business Services, Inc. (NASDAQ:BBSI)?

Barrett Business Services, Inc. (NASDAQ:BBSI), might not be a large cap stock, but it saw a significant share price...

Update: Atrion (NASDAQ:ATRI) Stock Gained 61% In The Last Five Years
Update: Atrion (NASDAQ:ATRI) Stock Gained 61% In The Last Five Years

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But in our...

Anika Therapeutics (NASDAQ:ANIK) Share Prices Have Dropped 52% In The Last Year
Anika Therapeutics (NASDAQ:ANIK) Share Prices Have Dropped 52% In The Last Year

Even the best stock pickers will make plenty of bad investments. Anyone who held Anika Therapeutics, Inc...

ANGI Homeservices (NASDAQ:ANGI) Shareholders Booked A 51% Gain In The Last Year
ANGI Homeservices (NASDAQ:ANGI) Shareholders Booked A 51% Gain In The Last Year

ANGI Homeservices Inc. (NASDAQ:ANGI) shareholders might understandably be very concerned that the share price has...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business